Ariella Shoham

Sana Klinikum Lichtenberg partners with Aidoc, introducing AI for prioritization of suspected lung blood clots to one of its largest hospitals

Germany’s leading private hospital group integrates Aidoc’s medical imaging solution for pulmonary embolism at Sana Klinikum Lichtenberg

Aidoc, the leading provider of AI healthcare solutions, today announced a partnership with Sana Klinikum Lichtenberg, one of the largest of the German private hospital network’s 55 facilities, which treats hundreds of thousands of patients annually. Lichtenberg Hospital will now integrate Aidoc’s AI algorithm for pulmonary embolism (PE) to aid radiologists in prioritizing suspected findings of pulmonary embolism (lung blood clots), which can be a life threatening pathology.

Findings from a Sweden-based study on the thrombotic  suggest that patients who experienced extreme or even mild Covid-19 symptoms are at a significantly higher risk for a pulmonary embolism (lung blood clot) for up to six months post-recovery.  Patients experiencing a PE can face a mortality rate as high as 30%, if left untreated. With an increased likelihood among patients infected with and recovered from Covid-19 to experience a blood clot, Sana’s radiologists will be utilizing Aidoc’s PE AI solution to help radiologists triage acute cases of lung blood clots.

“The pandemic has posed numerous challenges within healthcare across Germany, pushing hospital capacities to their limits. But we’ve identified technologies like artificial intelligence as powerful tools to provide the kind of support our radiology departments need to expedite care and manage higher volumes, especially with research showing higher prevalence of cases like PE,” says Michael Kabiersch, CEO at Sana Klinikum Lichtenberg. “In Aidoc, we’ve identified a partner with a strong reputation for artificial intelligence and a deep knowledge on how to integrate into our existing systems without disrupting day-to-day routine, while also having the ability to complement our physicians in sustaining a high level of diagnostic accuracy.” 

In a clinical study on the capacity of Aidoc’s pulmonary embolism (PE) solution, researchers at University of Basel Hospital concluded that the AI “showed a high degree of diagnostic accuracy for the detection of pulmonary embolism on CTPAs” (92.7% sensitivity and 95.5% specificity) and “speed up the diagnostic and therapeutic workup of patients with pulmonary embolism.” In further clinical research on Aidoc’s numerous CE-marked algorithms, results suggested that Aidoc’s AI could also help physicians reduce the length of stay, reduce the time to reporting an abnormality and improve patient outcomes.

“We are excited to extend our work in Germany and partner with another outstanding organization like Sana Kliniken Berlin-Brandenburg, an organization clearly dedicated to the improvement of patient outcomes and harnessing the latest innovations to manifest it,” said Alexander Boehmcker, Aidoc’s VP Europe. “Covid-19 can become a catalyst for AI adoption across European healthcare systems and with tools like Aidoc’s PE algorithms, radiologists can be empowered to better prioritize cases of pulmonary emboli they might not otherwise have anticipated to find and ensure the patient receives the care they need.”

About Aidoc

Aidoc is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance efficiencies. Aidoc’s AI-driven solutions analyze medical images directly after the patient is scanned, suggesting prioritization of time-sensitive pathologies, as well as notifying and activating multidisciplinary teams to reduce turnaround time, shorten length of stay, and improve overall patient outcomes.

Explore the Latest AI Insights, Trends and Research

Ariella Shoham